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Disrupted interoception is a prominent feature of the diagnostic classification of several 
psychiatric disorders. However, progress in understanding the interoceptive basis of 
these disorders has been incremental, and the application of interoception in clinical 
treatment is currently limited to panic disorder. To examine the degree to which the scien-
tific community has recognized interoception as a construct of interest, we identified and 
individually screened all articles published in the English language on interoception and 
associated root terms in Pubmed, Psychinfo, and ISI Web of Knowledge. This search 
revealed that interoception is a multifaceted process that is being increasingly studied 
within the fields of psychiatry, psychology, neuroscience, and biomedical science. To 
illustrate the multifaceted nature of interoception, we provide a focused review of one 
of the most commonly studied interoceptive channels, the cardiovascular system, and 
give a detailed comparison of the most popular methods used to study cardiac intero-
ception. We subsequently review evidence of interoceptive dysfunction in panic disorder, 
depression, somatic symptom disorders, anorexia nervosa, and bulimia nervosa. For 
each disorder, we suggest how interoceptive predictions constructed by the brain 
may erroneously bias individuals to express key symptoms and behaviors, and outline 
questions that are suitable for the development of neuroscience-based mental health 
interventions. We conclude that interoception represents a viable avenue for clinical 
and translational research in psychiatry, with a well-established conceptual framework, 
a neural basis, measurable biomarkers, interdisciplinary appeal, and transdiagnostic 
targets for understanding and improving mental health outcomes.
Keywords: interoception, heartbeat detection, panic disorder, depression, anorexia nervosa, bulimia nervosa, 
somatic symptom disorders, exposure therapy
iNTRODUCTiON
Recent interpretations of the limited impact of psychiatric neuroscience and genetics research on 
treatment outcomes have argued that the time has come for a pragmatic shift in focus through the 
identification of biomarkers with a mechanistic focus (1) and pursuit of processes that predict illness 
course or treatment outcome (2). In the current review, we explore how the study of interoception 
represents an enticing yet underutilized opportunity to apply neuroscience-based approaches to the 
TABLe 2 | Facets of interoception.
Facet Operational definition Paradigms
Attention Observing internal body 
sensations
C*, GI* Simmons et al. (14)
R* Farb et al. (15)
Detection Presence or absence of 
conscious report
C* Khalsa et al. (16)
C* Garfinkel et al. (17)
R* Davenport et al. (18)
R* Paulus et al. (19)
GI* Holzl et al. (20)
Magnitude Intensity C*, R* Khalsa et al. (21)
R* Davenport et al. (18)
GI* Herbert et al. (22)
GI* Naliboff et al. (23)
U* Jarrahi et al. (24)
Discrimination Localize sensation to a specific 
channel or organ system, 
and differentiate it from other 
sensations
C*, R* Khalsa et al. (21)
GI* Aziz et al. (25)
Accuracy (or 
sensitivity)
Correct and precise monitoring C* Schandry et al. (26)
C* Khalsa et al. (8)
R* Daubenmier et al. (27)
Self-Report Reflect upon one’s own 
experiences of interoceptive 
states, make judgments about 
their outcomes, and describe 
them through verbal or motor 
responses
Shields et al. (28)
Porges (29)
Labus et al. (30)
Khalsa et al. (16)
Mehling et al. (31)
Ceunen et al. (32)
Garfinkel et al. (33)
The illustrated paradigms cut across several organ systems including the cardiac (C*), 
respiratory (R*), gastrointestinal (GI*), and urinary (U*) systems (see Data Sheet S1 in 
Supplementary Material for detailed definitions).
TABLe 1 | Different definitions of interoception.
Author(s) Definition
Vaitl (5) A general concept, which includes two different forms of 
perception: proprioception and visceroception
Cameron (6) The afferent information that arises from anywhere and 
everywhere within the body – the skin and all that is 
underneath the skin, e.g., labyrinthine and proprioceptive 
functions – not just the visceral organs
Cameron (4) Perception of the functions and physiological activities of 
the interior of the body
Craig (7) The sense of the physiological condition of the body or 
a homeostatic afferent pathway that conveys signals 
from small diameter primary afferents that represent the 
physiological status of all tissues in the body
Khalsa et al. (8) The perception of internal body states
Paulus et al. (9) The central nervous system representation of visceral 
feelings
Couto et al. (10) The processing of bodily signals from the viscera and 
somatic tissues
Critchley and 
Harrison (11)
Continuous dynamic feedback of afferent visceral signals 
that shape (the brain’s) operational functioning
Paulus (12) A process consisting of integrating the information coming 
from the inside of the body in(to) the central nervous system
Barrett and 
Simmons (13)
The perception and integration of autonomic, hormonal, 
visceral and immunological homeostatic signals that 
collectively describe the physiological state of the body
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development of novel interventions, in ways that are pragmatic 
and mechanistic.
We start with an overview of interoception followed by an 
illustration of the natural history of interoception research. We 
demonstrate the multifaceted nature of interoception through a 
focused review of the most popular methods used to study cardiac 
interoception. To demonstrate the links between interoception 
and psychopathology, we review findings in several psychiatric 
conditions emblematic of abnormal interoception: panic disor-
der, depression, somatic symptom disorders, anorexia nervosa, 
and bulimia nervosa. We highlight parallel findings across these 
disorders and areas where progress could be made. We conclude 
by discussing interoception’s relevance to recent paradigm 
shifts in biomarker research in mental health, and underscore 
some practical considerations relevant to the development of 
interoception-based mental health interventions.
wHAT iS iNTeROCePTiON?
Interoception refers to the process of how the brain senses and 
integrates signals originating from inside the body, providing a 
moment by moment mapping of the body’s internal landscape. 
This crosstalk gives rise to urges, feelings, drives and emotional 
experiences under certain conditions, highlighting the impor-
tance of interoception for the maintenance of homeostatic func-
tioning, body regulation, and survival. The enduring parcelation 
of the body’s processing of internal and external signals into 
interoception, proprioception, and exteroception first occurred 
more than a 100 years ago (3, 4). Since then, numerous defini-
tions of interoception have been offered with sometimes subtle 
and at other times substantial variation (see Table  1). From 
these definitions, it is clear that interoception is a multifaceted 
process that can be deconstructed into different aspects such as 
attention, detection, discrimination, accuracy, and self report 
(Table  2 and Data Sheet S1 in Supplementary Material for 
selected definitions, and Box 1 for a discussion of taxonomy). 
Interoception encompasses both non-conscious and conscious 
levels of information processing, and the processing of painful 
and non-painful stimuli (Table 3).
THe NATURAL HiSTORY OF 
iNTeROCePTiON ReSeARCH
To examine the degree to which the scientific community has 
recognized interoception as a construct of interest, we identified 
and individually screened all articles published in the English lan-
guage on interoception and all associated root terms in Pubmed, 
Psychinfo and ISI Web of Knowledge (Figure  1, blue line). 
Interest in interoception research fluctuated during most of the 
twentieth century followed by a stratospheric increase during the 
twenty-first century, suggesting this area is currently undergoing 
a renaissance. However, interoception is a multifaceted phenom-
enon that is not restricted to conscious perception or even to the 
human species. When we identified articles directly assessing the 
different facets of interoception – but without including the term 
interoception directly  –  a different pattern emerged (Figure  1, 
orange line, and Data Sheet S2 in Supplementary Material). 
FiGURe 1 | Number of articles published on interoception versus 
articles published measuring interoceptive facets without directly 
referencing the concept. The timeline starts in 1905, 1 year before the 
publication of Charles Sherrington’s book, “The integrative action of the 
nervous system,” which introduced the term interoception into the literature.
TABLe 3 | Physiological processes that have been ascribed to 
interoception.
Non-painful: Cardiovascular, respiratory, gastrointestinal (esophageal, gastric, 
intestinal, colorectal), bladder, hunger, thirst, blood/serum (pH, osmolality, 
glucose level), temperature, vasomotor flush, air hunger, muscle tension, 
shudder, itch, tickle, pleasure, genital sensation, and sensual touch
Painful: Visceral: kidney, pleuritic, angina, pelvic, pericardial, muscular, sickle 
crisis; Somatic: abscess/boil, bruising, laceration inflammation, headache 
(migraine, ocular, cluster); Skeletal: broken/bruised bone, and stress fracture
BOX 1 | A note on taxonomy.
There currently exists some variability in interoception terminology. This is 
especially true at the self-report level, where distinctions have been made 
between measures of task accuracy, perceptions of task performance, and 
the relationship between the two (16, 32). Adding to this debate, Garfinkel 
et al. (33) have defined interoceptive awareness as metacognitive awareness 
or self-knowledge about interoceptive task performance, differentiating it from 
interoceptive accuracy. Others have referred to the confidence-accuracy 
correspondence as interoceptive coherence (34). Some have described 
interoceptive awareness in terms of an attentional bias (35) or simply objective 
task performance (36). Harmonizing these different perspectives into a unified 
taxonomy might provide a framework upon which comparative investigations 
across different psychiatric disorders could be made. We propose that the 
term “interoceptive insight” might reflect a more appropriate term for estima-
tes of confidence-accuracy correspondence, particularly within the context 
of studying psychiatric patient populations. There are likely many additional 
aspects of interoceptive self-report, including questionnaires [e.g., Ref. (28, 
31)] and assessments of dispositional tendencies [aka “interoceptive sensibi-
lity” (33), see Table 2]. Therefore, further parcelation of the self-report aspect 
of interoception represents an opportunity ripe for further investigation (37). 
See (37) for a historical analysis of interoception semantics.
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It  appears that interest and progress in studying interoceptive 
facets has been rising for the past quarter century, decades ahead 
of this concept, though mainly in biomedical, non-psychiatric 
fields. Next, we consider ways that some of these discoveries 
might be leveraged to advance progress in understanding the 
pathophysiology of psychiatric illnesses.
CAN iNTeROCePTiON PROviDe 
PRACTiCAL BiOMARKeRS?
Interoceptive processes have been delineated across all of the major 
biological systems involved in maintaining bodily homeostasis, 
including the cardiovascular (38, 39), pulmonary (40), gastroin-
testinal (41), genitourinary (42), nociceptive (43), ingestive (44), 
osmotic (45), thermoregulatory (46), and autonomic systems 
(11, 47). Many of these processes span the genetic, cellular, neu-
ral circuit, and systems levels, and they have been characterized 
extensively within separate branches of medicine and neurosci-
ence. To illustrate, consider the effects of hypercapnia associated 
with a prolonged breath hold (as might occur when swimming 
underwater) or an experimental analog, inhalation of carbon 
dioxide: pulmonary gas exchange is altered leading to a shifting 
of the oxygen–hemoglobin dissociation curve, reduced blood 
pH, bradycardia followed eventually by tachycardia, altered body 
temperature, activation of medullopontine apneustic rhythm 
generators and limbic cortical regions eliciting the subjective 
experience dyspnea, negative affect, and anxiety, leading to com-
pensatory hyperventilation and even potentially panic attacks 
(48–52). Accurate description of the processes at play requires 
holistic and integrative knowledge of respiratory physiology, 
basic neuroscience, functional neuroanatomy, medicine, clinical 
psychology and psychiatry, disciplines that are infrequently com-
bined within one approach [see Ref. (53) for a noteworthy excep-
tion]. This example illustrates how interoception can provide a 
direct bridge between biological and psychological functions, 
one cutting across diagnostic categorizations for psychiatric 
disorders. It also illustrates how interoception can function as 
a zone of convergence between classically distinct fields. Such 
comprehensive approaches have been advocated previously 
for assessing the different components of psychiatric disorders 
(54) but without an emphasis on interoception per se. Next, we 
describe multifaceted approaches to interoceptive assessment.
MULTiFACeTeD ASSeSSMeNT: THe 
eXAMPLe OF CARDiAC iNTeROCePTiON
To further illustrate the multifaceted nature of interoception, we 
focus here on one of the most commonly studied interoceptive 
channels: the cardiovascular system. Cardiac interoception can 
be defined as the process of sensing, storing, and representing 
information about the state of the cardiovascular system. Like all 
interoceptive modalities, cardiac interoception is a process that 
can be deconstructed into different aspects such as attention, 
detection threshold, symptom magnitude, accuracy, discrimi-
nation, or self-report. Each facet can be interrogated, and the 
literature is replete with such tasks.
To facilitate interpretation of the most common measures 
of cardiac interoception, we provide a side-by-side comparison 
(Figure 2). All of these tasks share in common a measurement 
of the cardiac signal in some form (e.g., via electrocardiogram or 
pulse oximeter). They all oblige individuals to voluntarily direct 
attention toward their feeling of the heartbeat (i.e., interoceptive 
attention), and they also require some form of self-report in order 
FiGURe 2 | Facets of cardiac interoception. Representative constructs, tasks, and exemplar studies from the literature. We recommend that future studies 
include multiple tasks evaluating the facets of cardiac interoception from converging perspectives (e.g., red and blue highlighted tasks). An analogous approach is 
recommended for other interoceptive sensory modalities (see text for details).
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to assess subjective experience. The first tasks developed to sys-
tematically study human cardiac interoception were non-invasive. 
They involve silently counting heartbeats during pre-specified 
time periods [“heartbeat counting” (55)], or tapping the finger 
or pressing a button to indicate each felt heartbeat [“heartbeat 
tapping” (56)], or comparing the heartbeat sensation with audi-
tory tones presented simultaneously or non-simultaneously with 
the heartbeat [“heartbeat detection” (57–59)]. These tasks have 
been characterized extensively by an outstanding generation of 
psychophysiologists [as summarized in Ref. (60)].
Decades of research have also revealed that each task has 
benefits and drawbacks. While heartbeat counting is easy to 
perform and analyze, the measure is potentially confounded by 
the influence of a priori knowledge of one’s own heart rate (61, 
62) and a reduced sensitivity to heart rate changes (63). Heartbeat 
tapping provides temporal detail about each felt heartbeat (unlike 
heartbeat counting) but requires a more sophisticated analysis 
approach and nuanced interpretation and so it has not been 
widely utilized (64–66). Heartbeat detection is the most complex 
task to implement, but it yields rigorous statistical measures of 
accuracy at the individual subject level based on signal detection 
theory (16, 67–70), which has contributed to a wide popularity. 
A recently developed minimalistic approach involves measuring 
brain activity while participants simply attend to the feeling of 
their heartbeat sensation (14). This allows for identification of 
brain regions involved in interoceptive attention with less of the 
potentially confounding effects of somatomotor responses or 
interoceptive–exteroceptive stimulus comparisons (as in heart-
beat detection for example). Because these tasks inherently load 
differently on the various facets, direct comparisons are rarely 
made. This may be partly related to the fact that interoception 
research is inherently cross-disciplinary: the same processes may 
be studied separately by a broad array of investigators, including 
psychologists, psychiatrists, physiologists, neuroscientists, and 
cardiologists utilizing techniques most accessible and specific to 
their interests and field.
One especially important point to note is that all of the afore-
mentioned tasks typically measure cardiac interoception under 
conditions of physiological rest. As a consequence, in the absence 
of an environmental manipulation, they fail to assess one of the 
most important characteristics of the cardiovascular system: 
that it dynamically responds to perturbations in the internal and 
external milieu, often resulting in changes in the intensity of per-
ceived cardiovascular sensations. In fact, when measured at rest 
(i.e., at a homeostatic set point), cardiac interoception is actually 
quite poor, with only about 35% of individuals typically able to 
accurately perceive their cardiac sensations (16, 60, 71–73). This 
low rate of detection is similar even following heart transplanta-
tion (74), which raises important questions about the neurovis-
ceral source of heartbeat sensations. These findings suggest that 
under resting conditions most individuals do not actually sense 
their heartbeat sensations, regardless of their self-report. Since 
clinically and/or emotionally significant events are arousing and 
frequently associated with dynamic disruptions in cardiovascular 
homeostasis (such as palpitations during a panic attack, public 
speaking anxiety, traumatic hypervigilance, physical exertion, or 
simply excited anticipation during a roller coaster ride or horror 
movie), these tasks may be failing to assess an important source 
of symptom variability under typical measurement conditions: 
interoceptive intensity.
An effective method for assessing individual differences in 
interoceptive intensity is by modulating arousal via the sym-
pathetic nervous system. Although different forms of exercise 
or postural changes can accomplish this (26, 73, 75, 76), such 
designs are limited by expectancies associated with this non-
maskable manipulation. On the other hand, pharmacological 
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manipulations have the advantage of a credible placebo manipu-
lation that allows for measurements of responding bias and 
assessment during physiological resting states.
Many different compounds have been shown to alter sympa-
thetic arousal and cardiovascular interoceptive intensity. These 
include isoproterenol (77, 78), sodium lactate (79–82), carbon 
dioxide (CO2) (83–87), caffeine (88–90), pentagastrin (91), 
doxapram (92, 93), cholecystokinin (94, 95), and yohimbine (96–
98). Many of these pharmacological probes require intravenous 
access. They are typically applied using a chronic administration 
format (i.e., continuous infusion or continuous inhalation), 
which hinders estimates of dose–response relationships. Such 
studies typically rely upon concurrent or retrospective question-
naire ratings of the intensity of multiple symptoms, usually due 
to a focus on negative affective processes such as gauging anxiety 
level and/or panic attack occurrence. That is, while they might 
include assessments of interoceptive symptom intensity, the study 
focus is usually broader and many of the other interoceptive fac-
ets (e.g., detection, discrimination, accuracy) are not evaluated. 
Each of these probes also have different pharmacological targets, 
and therefore the observed sympathetic arousal changes may 
occur as a non-specific downstream response to physiological 
perturbation.
Isoproterenol is one pharmacological agent that is well suited 
for studying cardiac interoception. It targets the cardiovascular 
system via stimulation of beta-adrenergic receptors, and its 
peripheral mechanism of action provides a potent probe of affer-
ent interoceptive processing (99). As there are beta-adrenergic 
receptors in the lungs, bronchodilation and associated respiratory 
sensations can also be elicited, though typically at a lower inten-
sity. This allows for the assessment of respiratory interoception 
and illustrates the close interactions between the cardiac and 
respiratory systems. Some participants may report autonomic 
symptoms such as dizziness or flushing and/or affective symp-
toms such as anxiety, particularly at higher levels of stimulation, 
e.g., 4 μg bolus (100), or during prolonged infusion (101).
Initial psychopharmacological studies of isoproterenol were 
clinical in nature and investigated its anxiogenic properties by 
applying continuous prolonged infusions (77, 78), with subse-
quent studies focusing more on peripheral leukocyte sensitivity 
during bolus infusion administration (102–104). More recently, 
bolus infusions of lower doses of isoproterenol (0.1. 0.25, 0.5, 0.75, 
1.0, 2.0, and 4.0 μg) have been used to study cardiac interoception 
in psychiatric and neurological patient samples (21, 100, 105). 
During this type of task, participants receive isoproterenol or 
saline infusions in a double-blinded protocol. They concurrently 
rate the intensity of perceived cardiorespiratory sensations by 
rotating a dial, and retrospectively rate cardiac, respiratory, and 
autonomic/affective symptom intensity individually. Although 
this task is invasive and requires physician supervision, it pro-
vides good experimental control over the cardiovascular system. 
It also enables accurate measurement of all facets of cardiac 
interoception: dichotomized dial ratings reflect interoceptive 
detection, cross correlations between heart rate and dial ratings 
reflect interoceptive accuracy, different doses provide measures 
of interoceptive intensity, placebo infusions enable estimates of 
interoceptive discrimination, and post hoc questionnaires assess 
the participant’s self-report of the task (e.g., experienced loca-
tions of perceived heartbeat sensations, task difficulty/tolerabil-
ity, likelihood of drug versus placebo administration, etc.) (21). 
Interoceptive responses to bolus isoproterenol infusions have 
been well characterized in healthy populations: at high enough 
doses (e.g., 2 μg and above), cardiac interoceptive changes are 
correctly perceived by 100% of healthy individuals (8, 21, 100, 
105). Neural regions supporting the perception of isoproterenol-
induced cardiorespiratory sensations have also been investigated 
and include but are not necessarily restricted to the insular cortex, 
somatosensory afferent system (8, 101, 106) and the basolateral 
amygdala (100).
iNTeROCePTive DYSFUNCTiON 
AND PReDiCTiON eRRORS 
iN PSYCHOPATHOLOGY
Despite the many intersections between interoception and differ-
ent fields of medicine, it is surprising that this area has received 
a relatively sporadic exploration of within psychiatry. Disrupted 
interoception is prominently featured in the diagnostic clas-
sification of several psychiatric disorders, notably anxiety and 
depressive disorders, eating disorders, and somatic symptom 
disorders (44, 107). Furthermore, interoceptive symptoms are 
readily accessible by patient self-report, allowing for integration 
in routine psychiatric assessment and treatment protocols.
New theoretical insights into how the brain perceives the body 
may be informative in interpreting interoceptive dysfunction in 
psychiatric disorders. While it is customary to believe that visceral 
sensations arise from direct perception of the internal state of the 
body via ascending afferent pathways, new perspectives suggest 
that the brain works somewhat differently. Instead of a linear 
translation from sensations to perceptions, it may be accurate to 
say that interoceptive perceptions are constructed by the brain. 
Interoception may actually occur through an active and iterative 
process of comparing the brain’s anticipation of sensation with 
concurrently incoming sensation, indicating that interoceptive 
experiences may substantially reflect predictions about the state 
of the body (13, 108, 109). In this view, interoceptive experience 
is still exemplified by ongoing visceral sensations, but it can 
be modified or constrained to variable degrees by the brain’s 
anticipatory signals. If the actual state of the body differs from 
the predicted state, this results in a so-called “prediction error.” 
When prediction errors are small or non-existent, the system can 
be said to be in homeostasis. When prediction errors are large, 
incoming interoceptive information is decoupled from the brain’s 
interoceptive predictions. In the setting of psychiatric illnesses 
like anxiety and depression this system becomes imbalanced, 
producing “noisy” afferent input (110). In this view, beyond 
simply changing the external environment, the brain may also 
try to reduce interoceptive prediction errors by (1) selectively 
attenuating the processing of incoming sensory input, (2) by 
triggering changes in the body that resemble the expected (i.e., 
predicted) input, or (3) by altering perceptual inferences about 
bodily states. It may be possible that interoceptive dysfunction 
is marked by active attempts to modulate the relative value of 
incoming inputs in order to restore balance, and be the basis for 
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certain symptom reports and pathological behaviors observed 
in psychiatric patients such as frequent requests for reassurance, 
excessive treatment seeking, avoidance, or escape.
Next we consider several psychopathological conditions 
emblematic of abnormal interoception: panic disorder, somatic 
symptom disorders, depression, anorexia nervosa, and bulimia 
nervosa. This list is by no means inclusive, but is provided for 
illustrative purposes. Other relevant disorders worthy of attention 
that are not considered here include generalized anxiety disorder, 
posttraumatic stress disorder, social anxiety disorder, and others. 
We do not explicitly address the role of interoception in allostasis 
(111), stress (36), or animal and human neuroanatomy (7, 38), as 
these topics have been previously described in detail.
PANiC DiSORDeR: THe PROTOTYPiCAL 
iNTeROCePTive DiSORDeR
A survey of the literature on interoception and panic disorder 
suggests a somewhat conflicting picture. On one hand, most 
resting measures of cardiac interoceptive accuracy have failed 
to clearly demonstrate whether panic disorder patients perceive 
heartbeat sensations differently or whether they have a systematic 
bias toward reporting such feelings (112–114). This contrasts 
with many studies showing that panic disorder patients perceive 
cardiovascular sensations more intensely when stimulated 
pharmacologically via caffeine ingestion (88, 90), CO2 inhalation 
(115), or intravenous infusion with sodium lactate (116), yohim-
bine (97), cholecystokinin (117), or isoproterenol (77).
One way to reconcile these differences is in reiterating the 
aforementioned point that interoception under resting physi-
ological conditions may not have as much biological salience 
as during non-homeostatic deviations, which can signal threats 
to survival  –  be they physical, emotional, or social. Another 
point is that most pharmacological studies have been conducted 
within the field of psychiatry, whereas most psychophysiological 
studies have been conducted within the field of psychology; it is 
therefore possible that this gap in the literature is related partly to 
an incomplete overlap between these disciplines. An important 
historical factor potentially contributing to this discrepancy is 
that much of the early pharmacological studies were focused on 
finding a single biological target, or a single pathway in the central 
nervous system that might explain panic anxiety. When multiple 
agents with different binding sites produced panic similarly, it 
appears that interest in this theory waned rapidly and research 
in this area declined. Also, the observations that panic anxiety 
could be effectively attenuated by medications modulating the 
serotonergic and/or noradrenergic systems (118–125) or GABA-
ergic system (126–131), with success rates higher than most 
other psychiatric disorders, may have contributed to a relatively 
rapid shifting of funding priorities to other disorders. We should 
note that these developments do not rule out the possibility of 
identifying clinically relevant biomarkers for panic disorder. 
For example, respiratory muscle tension has been identified as a 
generator of dyspnea in individuals predisposed to panic disorder 
(132), and levels of cortisol have been found to moderate clinical 
improvement during exposure therapy for individuals with panic 
disorder (133).
Currently, the most common clinical application of interocep-
tive principles is the use of interoceptive exposure during the 
psychotherapeutic treatment of panic disorder (134–136). In this 
treatment approach, which is often implemented within cognitive 
behavioral therapy, the patient’s interoceptive triggers of anxiety 
are individually assessed in preparation for conducting intero-
ceptive exposures. Examples include assessing dyspnea sensitivity 
via rudimentary inspiratory loading (breathing through straws 
of different diameters), palpitation sensitivity via light exercise 
(pushups or jumping jacks), dizziness sensitivity via spinning in 
a chair, tingling sensitivity via hyperventilation, and flushing sen-
sitivity via sitting in front of a heater. Anxiety levels during each 
manipulation are recorded, generating a rudimentary “intero-
ceptive profile.” During the ensuing exposure phase patients 
voluntarily choose to experience these sensations in a repeated 
fashion, gradually working their way up a hierarchy to their most 
anxiogenic triggers in a process intended to elicit habituation and 
extinction to interoceptively triggered panic, resulting in reduced 
maladaptive avoidance and escape behaviors. In the outpatient 
clinic setting, these manipulations are variably effective at elicit-
ing anxiety, with some patients being more sensitive to respira-
tory cues and others more sensitive to cardiac or dizziness. Some 
patients develop rapid tolerance to these measures despite the 
presence of continued panic attacks.
Despite the established clinical efficacy of standard interocep-
tive exposure for anxiety disorders, it is noteworthy that this 
technique suffers from limited utilization with only 12–20% 
of psychotherapists reporting including it in their treatment 
approach (136). This has led some to refer to interoceptive 
exposure as “the single least utilized evidence-based anxiety 
treatment” (137). Putative barriers to utilization include a lack 
of training sites, logistical hurdles (e.g., occasional need for 
exposure durations longer than a standard therapy session), 
policies against conducting exposures outside of the workplace 
setting, and perhaps most tellingly, negative therapist beliefs (e.g., 
that interoceptive exposures are unethical, intolerable, or even 
harmful) (137).
The clinical evidence reviewed here implies that individuals 
with panic disorder may have differential sensitivity to interocep-
tive cues producing increased arousal. It also begs the question of 
whether utilizing more potent cues during interoceptive expo-
sure could boost the efficacy of this intervention. For example, 
panic disorder patients show increased autonomic arousal and 
heightened anxiety during exposure to experimental paradigms 
involving non-pharmacological approaches (being trapped in 
a small dark chamber) (138) as well as pharmacological ones 
(oral caffeine ingestion) (139). There is experimental evidence 
that pharmacological interoceptive exposure therapy can reduce 
anxiety disorder symptom severity either as a monotherapy (84, 
140–142) or as an augmentative approach (143). Finally, there is 
the question of whether modulating both physiological homeo-
stasis and the perception of controllability might further improve 
the ecological validity and efficacy of interoceptive exposures 
(144). However, there are few studies to date, the impact of such 
interventions on longer term outcomes (e.g., 6 months or beyond) 
are unknown, and none of these approaches have translated into 
regular clinical practice.
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Substantial barriers to implementation of an augmented 
approach exist under standard clinical conditions. For example, 
approaches using more potent interoceptive exposures, such 
as CO2 inhalation or isoproterenol infusion, carry with them 
increased requirements for medical screening and monitoring, 
reduced applicability in patients with significant medical comor-
bidity, and undoubtedly would be more expensive. The evidence 
base to date is insufficient to determine whether augmented 
approaches might be worth considering in a standard clinical 
setting. This might change if studies showed a substantially supe-
rior efficacy to standard interoceptive exposures. Despite these 
challenges, interoceptive exposure is currently a well established 
tool for the treatment of panic disorder. It has been integrated 
into transdiagnostic treatments, and it is being increasingly 
emphasized as an effective strategy (136).
Finally, there are currently no interoceptive biomarkers in 
clinical use to monitor outcomes and track illness course in panic 
disorder. This raises several questions. With all of the history of 
work in this area, why has not there been further progress? Can 
interoceptive biomarkers truly improve the characterization or 
treatment of panic disorder? With all of the focus on the physi-
ological mechanisms of interoception, can we afford to ignore the 
fact that psychological processes can also provide considerable 
therapeutic contributions? (144–148) These questions highlight 
some of the opportunities and challenges for translational devel-
opment of exposure-based treatments for panic disorder.
DAMPeNeD iNTeROCePTive 
eXPeRieNCe iN DePReSSiON
Interoceptive dysfunction has been theoretically linked to depres-
sion and major depressive disorder (MDD) [for reviews, see 
Ref. (35, 110)]. In aggregate, the available data seems to suggest 
that depression is associated with blunted cardiac interoceptive 
awareness. Women with MDD show lower accuracy on heartbeat 
counting (149). MDD patients of both genders display lower 
accuracy than healthy comparisons on a heartbeat counting 
task (150). Performance on heartbeat counting tasks has been 
negatively correlated with symptoms of depression (151), and in 
a separate study, associated with reduced positivity and reduced 
decision-making ability (149). Depressed patients also exhibit 
comparatively lower heartbeat counting accuracy than patients 
with panic or anxiety disorders (152).
Poorer resting heartbeat interoception is not always seen in 
depression. In a study comparing healthy participants to mod-
erately depressed and severely depressed patient samples, the 
severely depressed sample showed higher heartbeat counting 
scores than the moderately depressed sample (153). Although 
the authors controlled for many aspects of individual differences 
between the moderately depressed community and clinical 
population, as a group, the more severely depressed patients were 
also higher in anxiety, which might have explained differences in 
accuracy. Indeed, in a follow-up study by the same group, poor 
heartbeat counting accuracy was observed in a depressed sample 
but found to increase as a function of reported anxiety (154).
Interpreting the varying heartbeat counting findings in 
depression requires some conjecture. Given that most individuals 
are unable to feel their heartbeat sensations at rest, one possibility 
is that scores on this task are prone to a certain form of exagger-
ated symptom report. One can speculate that in the setting of 
anxiety, symptom reports are biased by the issuing of increased 
or exaggerated anticipatory prediction errors, which produces 
higher counts and higher accuracy scores. In depression on the 
other hand, interoceptive prediction errors might operate in the 
opposing direction, leading to lower counting rates.
In both cases, the insular and anterior cingulate cortices would 
be considered key structures involved in generating prediction 
errors, and indeed there is evidence of altered functioning in 
these regions in depression (155, 156). In a noteworthy study, 
Avery et  al. (157) found that depressed patients displayed 
decreased activation in the dorsal mid-insula when attending 
to interoceptive sensations relative to healthy comparisons, and 
connectivity between the dorsal mid-insula and other limbic 
structures predicted depression severity. In a different study 
using heartbeat counting, depressed patients showed reduced 
activity in the anterior insula, and this signal correlated with 
depression severity (158). Interpreting these findings within an 
interoceptive prediction error framework, it appears possible that 
the interoceptive attention only condition [i.e., Ref. (157)] may 
have activated a more posterior sensory region of the insula (in 
fact, directly at the termination site of vagal afferent projections) 
whereas the heartbeat counting condition, which can be more 
sensitive to bias (61, 62), activated a more anterior region of the 
insula. One can speculate that the anterior insula signal directly 
reflects the source of interoceptive predictions, and therefore 
could represent a key contributor to prediction error signals. 
A way to verify this would be to perform both the interoceptive 
attention and heartbeat counting tasks in the same individuals 
and determine whether the same anterior–posterior gradient of 
activation was observed. Another way would be to study neural 
processing during the anticipation and receipt of a homeostatic 
perturbation, and evaluate whether differential anterior insular 
activation during the anticipatory but not perturbation period 
occurred for one patient group versus another.
With respect to homeostatic perturbations, studies in 
depressed patients are limited, and findings are mixed. Some 
studies suggest hyperactive sympathetic responding and oth-
ers suggesting attenuated responsiveness [see Nemeroff and 
Goldschmidt-Clermont (159) for a review]. In response to an 
oral yohimbine challenge patients with MDD reported higher 
levels of palpitations, restlessness, flushing, sweating, tremors, 
and anxiety than healthy comparisons (160). In a different study, 
patients with depression were more tolerant than panic disorder 
patients to the effects of inhalation of 5% and a 7% carbon dioxide 
despite exhibiting similar increases in respiratory rate and tidal 
volume (85). This latter finding provides additional evidence of 
dampened interoceptive reactivity in MDD compared to panic 
disorder, though the rationale for why this was observed for a 
respiratory as opposed to cardiac challenge is unclear.
These findings have contributed to several theoretical mod-
els of depression in which altered interoception is a putatively 
key phenomenon. Paulus and Stein (110) characterize this as 
an altered signal to noise ratio with noisy interoceptive input at 
baseline preventing individuals from gaining an accurate picture 
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of their internal bodily landscape. Northoff et al. hypothesize that 
decreased sensitivity to exteroceptive stimuli results in reduced 
neural activation to exteroceptive signals, leads to an imbalance 
between the processing of interoceptive versus exteroceptive 
signals, and a relative increase in the prominence of interoceptive 
information (161). Harshaw (35) attempts an integration of these 
views, by discussing three potential interoceptive “pathways” to 
depression: direct modification of insula functioning, decreased 
sensitivity to social cues causing interoceptive changes, and dis-
ruptions in interoceptive attentional capacity perhaps related to 
increased rumination. While further studies are needed to ascer-
tain the veracity of these theoretical models, a recent finding that 
the insula and putative reward regions show differential responses 
based on whether appetite has decreased or increased in depres-
sion (poorer response the former and increased response in the 
latter) suggests a more complicated picture with the potential 
for multiple subtypes based on neural and behavioral symptom 
clustering (162).
Finally, altered immune function has also been observed in 
depression (163, 164). While immune processing clearly repre-
sents an important form of interoceptive processing, a detailed 
discussion is beyond the scope of the current review. It is worth 
simply noting that from a methodological standpoint, infusions 
of inflammatory markers (e.g., endotoxin) have been observed 
to stimulate rapid but transient changes in mood (depressed 
mood), increased autonomic tone (temperature and blood pres-
sure), and cytokine production (165). This type of approach may 
represent another viable experimental framework for investigat-
ing relationships between depression, immune function, and 
interoception.
HeiGHTeNeD iNTeROCePTive 
SiGNALiNG iN SOMATiC SYMPTOM 
DiSORDeRS
Somatic symptom disorders have received less attention in the 
interoception literature compared with other areas of psychopa-
thology. Reviewing this literature is somewhat complicated by 
the recent change in categorization from somatoform disorders 
in DSM 4 to somatic symptom disorder and related disorders 
in DSM 5 (166). The fact that somatization is quite common in 
anxiety and depressive disorders poses an additional challenge 
to disentangling symptom reporting due to somatic symptom 
disorder versus those stemming from affective processes (167, 
168). As a result of these considerations, we have widened our 
discussion to include pain processing among patient and non-
patient populations, as well as those showing evidence of altered 
somatosensory responding.
Despite the exaggerated symptom reports, interoceptive accu-
racy seems to be poor in somatic symptom disorders. Patients 
with psychosomatic disorders score lower on heartbeat counting 
tasks than healthy controls (169). Medical outpatients being 
evaluated for palpitations also exhibit low resting heartbeat detec-
tion accuracy despite a tendency to overstate their experience of 
palpitations (170). They also have high psychiatric comorbidity: 
in a small study, over 25% of these had a lifetime prevalence 
of panic disorder, and almost 50% had a lifetime prevalence of 
another psychiatric disorder (171). Medical outpatients who 
were more anxious and stressed reported physical symptom 
discomfort at lower heart rates during an exercise treadmill test, 
indicating poorer interoceptive distress tolerance (74). These 
elevated comorbidity rates and poorer interoceptive distress tol-
erance raise the possibility that both panic and somatic symptom 
disorders share some overlapping dysfunction, perhaps in neural 
circuitry underlying the heightened attention toward and nega-
tive interpretation of interoceptive signals.
Environmental context also appears to play a role in symptom 
reporting in somatization. For example, during a rebreathing test 
intended to increase pCO2 levels in the blood, high symptom 
reporters performed accurately when given neutral cues about 
the stimulus (“the gas mixture might alter breathing behavior and 
induce respiratory sensations”) but when given negative harm 
cues about the stimulus (“the gas mixture might alter breathing 
behavior and induce respiratory symptoms”) they performed 
worse and endorsed higher dyspnea (172). Another study showed 
that individuals reporting high amounts of physical symptoms 
exhibited a bias toward overestimating the intensity of inspiratory 
breathing loads when they were closely spaced together (173). 
It seems plausible that interoceptive prediction error signaling 
might explain some of these exaggerated symptom reports, such 
that the symptom report is generated by an inappropriately 
heightened sense of anticipation.
Interoception has also been studied in relation to somatosen-
sory amplification, or the propensity to interpret signals arising 
from within the body as disproportionally intense, noxious, or 
disturbing (174). Patients with non-cardiac chest pain have higher 
somatosensory amplification scores despite similar heartbeat 
detection accuracy compared to a sample of patients with cardiac 
chest pain (175). They also have higher healthcare utilization 
and poorer outcomes (176). In a cross sectional study of medical 
outpatients, somatosensory amplification was positively associ-
ated with self-reported body awareness, somatic symptoms, and 
trait anxiety (177). Despite these findings in clinical populations, 
healthy participants performing better than chance on heartbeat 
detection had significantly lower scores on the somatosensory 
amplification scale (178, 179).
Somatosensory amplification involves more than interocep-
tion. It includes heightened self-scrutiny, increased attention to 
weak or infrequent bodily sensations, the tendency to appraise 
ambiguous stimuli negatively, and to interpret them as patho-
logical or symptomatic of disease (180). Since several of these 
processes, including negative self appraisal and heightened self 
scrutiny, are also features of anxiety and depression (181), it seems 
possible that the tendency to over endorse interoceptive symp-
toms in somatic symptom disorders could be driven by overlap 
between the conditions. On a more parsimonious note, symptom 
reporting in both types of disorders may be driven by a similar 
source  –  increased anticipatory neural signals in interoceptive 
regions of the brain including the insula and anterior cingulate. 
Once can speculate that reduced interoceptive accuracy in the 
presence of exaggerated symptom reporting might reflect the 
presence of interoceptive prediction errors in these illnesses, 
and an associated pathology in the brain’s predictive machinery. 
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This could account for how exaggerated bodily symptom reports 
generate the prototypical behavior of these disorders: repeated 
treatment seeking for a medical explanation. This view also offers 
a novel framework from which to extend our understanding of 
the neural basis of these “functional” disorders by applying the 
methodology of prediction.
Identifying the presence of interoceptive prediction errors in 
somatic symptom disorder patients might also provide a basis 
for treatment. A review of interoceptive fear conditioning in 
chronic pain conditions suggested that the fear of pain stem-
ming from interoceptive prediction errors may be a powerful 
motivator in panic disorder and somatic symptom disorders 
(182). Furthermore, interoceptive fear was found to mediate 
the relationship between body vigilance and chest pain for 
non-cardiac chest pain patients (183). Whether interoceptive 
exposure therapy could extinguish fearful apprehensions of 
internal bodily sensations in somatic symptom disorders is pres-
ently uncertain. However, one expectation following from such 
a finding would be that somatic symptom exaggeration would 
be markedly attenuated following successful treatment in these 
patient populations, and would be associated with a reduced fre-
quency of inappropriate treatment seeking. Exposures could even 
be tailored to a patient’s individual symptoms. For example, if a 
patient’s concerns were centered around non-cardiac chest pain, 
exposures pertaining to cardiac events could be designed (run-
ning on a treadmill, pharmacological manipulation). Assessment 
for symptom attenuation and/or reduction in frequency of 
unnecessary medical presentations would be conducted routinely 
to document and evaluate progress. If the interoceptive exposures 
did in fact reduce symptom reporting, not only would this novel 
approach be useful in treatment, but it would provide further 
support for an etiological link between disrupted interoceptive 
awareness and somatic symptom disorders.
BiASeD iNTeROCePTive SiGNALiNG 
iN ANOReXiA NeRvOSA
Ever since the term anorexia nervosa (AN) was coined (184), 
clinical descriptions of AN portrayed interoceptive disturbances: 
patients with AN were apprehensive not just about eating food 
but also about their bodies. And while they were preoccupied 
with abnormal perceptions of their body exterior, as in the “fear 
of becoming fat,” they also frequently worried about abnormal 
experiences happening inside of the body. Classic case reports 
even emphasized “vague feelings of fullness” (185) or “a failure of 
recognizing bodily states” (186) as key illness characteristics. This 
has led to prominent modern theoretical accounts supporting the 
idea that interoception in abnormal in AN (44, 187–189).
Interoceptive dysfunction in AN can also be located within 
descriptions of “emotion dysregulation” (190), “poor distress 
tolerance,” (191) and perhaps most tellingly, “alexithymia” or the 
inability to discriminate between emotional states and bodily 
sensations (192, 193). Despite these perspectives, the phenotype 
of external body image disturbance continues to permeate diag-
nostic nosology. It remains a core feature of AN in DSM 5, leaving 
the phenotype of interoceptive dysfunction in AN comparatively 
unexplored.
At the self-report level, the Eating Disorder Inventory (EDI) 
(194) is a tool intended to assess psychological and behavioral 
traits in AN and bulimia nervosa [for a review, see Ref. (187) 
as well as (195–200)]. It has eight subscales, one of which was 
originally called the “Interoceptive Awareness” (IA) subscale. 
Abnormal scores on this subscale have been associated with AN 
for the original and subsequent versions, when it was renamed 
the “Interoceptive Deficits” subscale (201), and its popularity is 
reflected by translation into multiple languages (202). A large 
prospective study even found that low scores on this subscale 
predicted risk for developing an eating disorder among 664 ado-
lescent girls (203). In fact, scores on this subscale show the best 
sensitivity and specificity of all the subscales at discriminating 
individuals with AN from healthy comparisons (202).
Despite the popularity of the EDI measure, there are a number 
of challenges posed by interpreting the IA subscale as a valid 
measure of interoception in AN. (1) It comprises 10 questions, 
only 2 of which directly refer to physiological states: confusion 
about hunger, and bloating after a small meal. The remaining 
questions assess difficulty in recognizing and labeling feeling 
states, a process more akin to alexithymia (204–206). Since the 
IA subscale also correlates significantly with alexithymia in AN 
(205), equating differences in self-report on this subscale to 
differences in visceral perception is challenging. (2) Variability 
in interoceptive subscale scores has also been observed. For 
example, retrospective studies of recovered AN individuals have 
reported abnormally lower (207) but also abnormally higher 
scores (195, 199) relative to healthy comparisons. Interpreting 
these differences represents a methodological challenge. (3) 
Several biological parameters have also been associated scores 
on the IA subscale (196–198, 200, 208), but these parameters do 
not conceptually fit together easily, limiting the clinical interpret-
ability of these observations.
Beyond interoceptive self-report, few studies have examined if 
cardiorespiratory interoception is impaired in AN. Patients with 
AN have been found to be less accurate at counting their resting 
heartbeat compared to an age- and sex-matched comparison 
group (209), whereas short-term food deprivation in healthy 
females increased heartbeat counting accuracy (210). In a larger 
but mixed sample of eating disorder patients using a different 
task, heartbeat detection, there was no evidence for differences in 
resting interoceptive accuracy (211). Methodological differences 
aside, none of these eating disorder studies assessed interocep-
tion across the range of physiological and affective perturbations 
relevant to homeostasis, meal consumption, and emotional 
experience.
In our initial study of interoceptive processing in AN, we 
applied randomized, double-blinded infusions of isoproterenol 
and saline during a pre-meal anticipatory state (expectation of 
eating a 1000 Calorie meal) and immediately after consuming 
said meal (21). We found that individuals with AN experienced 
cardiorespiratory sensations abnormally intensely, especially 
the sensation of dyspnea, but only during the meal anticipa-
tion period. The meal anticipation period was also marked by 
exaggerated detection of interoceptive symptoms during the 
saline infusions, i.e., false positives, when no cardiorespira-
tory changes had occurred. This provided the first promising 
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evidence supporting the idea that interoceptive prediction 
signaling is distorted in AN, as previously suggested by Kaye 
et al. (44). Abnormal interoceptive detection under conditions of 
expectation provides evidence supporting the notion that AN is a 
condition where, similarly to anxiety and depression, the baseline 
is “noisy” and signals are obscured (110). However, the findings 
from this study also suggest that this noisy baseline appears to 
be a contextually driven state: one modulated in part by the 
interaction of environmental, disorder-specific cues (anticipa-
tion of meal consumption), with changes in adrenergic tone. 
Whether altered interoceptive prediction signaling during meal 
anticipation contributes to phenotypes of high anxiety in AN or 
alternatively, might be explained by enhanced meal associated 
anxiety, is presently unknown.
Evidence for aberrant interoceptive encoding at neural levels 
in AN can be found in neuroimaging studies. Aversive interocep-
tive provocation consistently identifies a network involving the 
insula, anterior cingulate, somatosensory cortices, and amygdala 
in healthy individuals (101, 117, 212, 213). This putative “aversive 
anticipatory neurocircuit” shows abnormalities in eating disor-
ders. For instance, individuals who have recovered from AN (i.e., 
achieved a normal weight) demonstrate increased activation of 
the insula and anterior cingulate when anticipating anxiogenic 
stimuli – viewing food images (214, 215) or painful esophageal 
stimulation (216), but perplexingly, exhibit decreased insular 
cortex activation relative to healthy controls when actually tast-
ing a food stimulus (217). This exaggerated anticipatory neural 
response but dampened response to body stimulation in AN has 
been explained as a deficit in the integration of expected versus 
experienced bodily experiences – i.e., as an interoceptive predic-
tion error (44, 218, 219).
It is also worth noting at this point that the prevalence of anxi-
ety in AN has been increasingly underscored in epidemiological 
and genetic studies. Anxiety disorders are well known anteced-
ents to the diagnosis of AN (220, 221). They have a nearly 80% 
lifetime comorbidity with AN (222), with generalized anxiety 
disorder showing the highest point prevalence occurring in 40% 
of patients with AN (223, 224). Anxiety disorders even occur 
disproportionately in first-degree relatives of individuals with 
AN (225, 226). Collectively this has led to the suggestion that 
anxiogenesis contributes substantially to the risk of developing 
eating disorders (227, 228).
As noted previously, interoceptive prediction errors have 
also been hypothesized to explain core features of anxiety dis-
orders (110, 218), perhaps because the anticipation of aversive 
stimuli activates the same regions: insula, anterior cingulate, 
amygdala, and somatosensory cortex (229, 230). These regions 
show increased activation in anxiety disorders during anxiety 
evocation (231–234) and also during anxious rumination in AN 
(235), suggestive of shared dysfunction. Despite these and other 
indications of links between anxiety and eating disorders (236), 
there is a distinct lack of research into avenues of potentially 
shared pathophysiology, and the degree to which abnormalities 
in anticipatory neurocircuity overlaps across these conditions is 
unknown.
In terms of clinical implications, exaggerated interoceptive 
bias during pre-meal states in AN raises the question of whether 
interoceptive sensations might represent potent intermediary 
physical symptoms worth highlighting and targeting in treat-
ment, particularly surrounding feeding times. For example, 
meals are an inherently anxiety provoking experience in this 
population that may reinforce their ability to avoid eating. In 
this regard, it seems plausible that integrating interoceptive 
exposures into treatment for AN might be effective for extinc-
tion learning approaches employing food to extinguish condi-
tioned responses (227, 237). Current treatments grounded in 
principles of desensitization and extinction learning through 
repeated exposure to feared food cues (238, 239) have shown 
modest benefits on reducing pre meal anxiety and improving 
meal consumption (237, 240, 241). We propose that it might 
be possible to develop novel food-focused fear extinction 
procedures by pairing such treatments with pharmacologically 
augmented exposure to interoceptive sensations. For example, 
the repeated application of isoproterenol infusions during the 
pre meal period might reduce biased interoceptive anticipatory 
responding (BIAS) in AN by reversing fearful stimulus–response 
associations with eating. If reducing BIAS makes the experience 
of eating less fearful and more tolerable for individuals with AN, 
it might help to reduce the intense fear of gaining weight that is 
a core feature of this illness. Such a discovery would pave the 
way for clinical trials investigating the potential impact of reduc-
ing BIAS on improving weight restoration and maintenance, 
representing a novel approach forward in the treatment of this 
devastating illness.
DiSTORTeD iNTeROCePTiON 
iN BULiMiA NeRvOSA
Disturbed interoception has been consistently considered to be a 
feature of bulimia nervosa (BN). Many of these studies have been 
based on self-report measures and diagnostic interviews compar-
ing individuals with BN to healthy comparisons. For example, at 
the self-report level patients with BN endorsed more items on 
the eating disorders inventory (EDI) interoceptive awareness 
subscale than healthy controls (242). Furthermore, patients with 
BN exhibit associations between anticipatory anxiety, interocep-
tive awareness (assessed via the EDI), and body image distortion, 
a common feature of eating disorders (236).
In response to sodium lactate and isoproterenol infusions, 
individuals with bulimia nervosa report higher panic and anxi-
ety symptoms than healthy control subjects, despite experiencing 
a similar increase in sympathetic response (243). This would 
seem to align with the self-report observations above, and also 
suggests heightened interoceptive awareness and a negative 
attribution style toward interoceptive sensations. However, 
under resting physiological conditions, recovered BN patients 
have been observed to have reduced heartbeat counting accuracy 
(244) [but see Pollatos and Georgiou (245)]. Reduced sensitivity 
to other types of internal and external sensations have also been 
documented in BN. Patients with BN demonstrated increased 
thresholds for heat pain, particularly those who were engaged in 
binging and purging (246). Gastric capacity was also found to be 
larger in BN relative to obese patients or healthy comparisons 
(247). Altered gastric interoception was further supported by 
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evidence for differential responding to satiety signaling in a 
consumption paradigm: patients consumed significantly more of 
a yogurt shake than healthy comparisons, yet reported similar 
satiety ratings (248).
Neuroimaging studies also provide some support for altered 
interoceptive function in BN. Patients with BN showed increased 
activity in the insula and anterior cingulate cortex in response to 
food viewing relative to healthy comparisons (249). Even after 
recovery, women formerly affected by BN had high activity in 
the right anterior insula in response to sweet tastes, as compared 
to healthy comparison women (217). Compared to controls, 
patients with BN showed increased gray matter volume in the 
left orbitofrontal gyrus and the left anterior ventral insula (250), 
regions that have been implicated in taste processing and intero-
ception, respectively. Beyond the insula, somatosensory regions 
have also been implicated in the experience of interoceptive 
awareness (8, 101). Patients with BN have shown evidence of 
increased volume in somatosensory regions relative to healthy 
comparisons (251).
Although the aforementioned studies provide some initial 
evidence of dysfunctional interoceptive representation in BN, 
the pathophysiology underlying these patterns is far from clear. 
It might seem from the self-report and neuroimaging literature 
that there is a pattern of hypersensitivity to interoceptive signals 
in BN. However, the peripheral physiological evidence indicates 
a tendency toward both blunted and exaggerated responses to 
interoceptive perturbation. These contradictory findings also 
fail to disentangle potentially differing neural circuits underly-
ing binging (and associated urges) and purging (and associated 
emotional states such as guilt) (252).
There are also likely to be heterogeneous autonomic effects 
related to repetitive binging and purging. One can speculate that 
the large shifts in autonomic tone during repeated binging and 
purging might cause conditioning effects – habituation or even 
sensitization – toward internal bodily states. For example, it has 
been demonstrated that one unconditioned response, salivation 
due to food presentation, is attenuated in BN and normalizes 
following treatment (253). As an example of potential peripheral 
sensitization, individuals with BN show decreased baseline sym-
pathetic tone yet increased adrenergic sensitivity to isoproterenol 
(254). Prospective longitudinal studies of multilevel interocep-
tive processing in BN individuals across illness and recovery 
states might help to clarify the underlying pathophysiological 
transformations.
With respect to treatment, interoceptive exposure therapy in 
BN has primarily focused on repeated exposure to binge or purge 
cues (e.g., consuming a “forbidden” food or a large quantity of 
food without being allowed to purge). While this approach has 
shown increased efficacy over relaxation treatments, as many as 
50% of patients remain ill at long-term follow up (255, 256). In 
this context, it is worth noting that patients with BN tend to show 
the highest incidence of panic disorder comorbidity among eat-
ing disorders (224). Whether augmented interoceptive exposure 
treatment to reduce anxiety sensitivity would boost the efficacy 
of this form of treatment in BN is unclear. Next, we discuss the 
relevance of interoception to recent paradigm shifts in biomarker 
research in mental health.
iNTeROCePTiON AND RDOC
The implementation of the Research Domain Criteria (RDoC) 
by the NIMH can be viewed as an attempt at the organizational 
level to improve the discovery of novel biomarkers of psychiatric 
illness (257). Rather than focusing on clinical observations as a 
basis for diagnosis and selection of research samples, RDoC relies 
on targeted investigations across multiple dimensions of different 
biological systems to understand their relative contributions to 
psychiatric pathophysiology. Interoception is inherently compat-
ible with this framework, as it provides a direct bridge between 
biological and psychological processes in numerous mental 
health conditions. It appears to intersect with multiple RDoC 
domains, especially the arousal/regulatory systems, negative 
valence systems, and cognitive systems.
Given the broad systems covered by interoception, it could 
even be argued that interoception should represent its own 
domain. For instance, assessments of cardiorespiratory intero-
ception can be readily mapped into the multiple RDoC levels of 
Self-report [e.g., Multidimensional Assessment of Interoceptive 
Awareness scale (31)], Behavior (e.g., heartbeat intensity rating), 
Physiology (e.g., heart rate, breathing rate, and blood pressure 
response), Neural Circuits (e.g., insula response) (8, 14, 101), 
Cells (e.g., glomus cells in the carotid sinus, baroreceptors in 
the aortic arch) (47), Molecules (e.g., beta-adrenergic receptor 
agonism), and Genetics [e.g., Single Nucleotide Polymorphisms 
associated with autonomic hypersensitivity (258)]. An occasion-
ally overlooked point is that the RDoC framework is not set in 
stone. At its inception a number of domains were proposed, and 
associated constructs and sub-constructs were defined during 
workshop proceedings according to workgroup consensus. While 
the resulting matrix covers many areas of research in psychiatry, 
some key gaps remain and at the organizational level NIMH 
has expressed openness to adding domains in the future. In the 
following section, we consider practical issues pertaining to the 
assessment of interoceptive constructs.
eXiSTiNG TeSTS wiTH KNOwN 
CONSTRUCT vALiDiTY
The interoceptive tests with the greatest construct validity appear 
to be those in which a homeostatic perturbation is induced and 
compared with the associated physiological change and symptom 
report. Many of these are somewhat invasive due to the inher-
ent nature of studying an internal bodily process, and they can 
sometimes induce negative affect. Examples on the more invasive 
spectrum include anorectal balloon distension to assess gastroin-
testinal sensitivity (23), urinary catheterization to assess bladder 
sensitivity (24), and intravenous infusions of isoproterenol to 
assess cardiac and respiratory sensitivity (16). Less invasive 
examples include carbon dioxide inhalation (83–87), transient 
inspiratory breathing restriction (18, 19), and the cold pressor 
task (259). These latter tasks are well suited to studying interocep-
tion in unique populations that might not tolerate a more invasive 
approach, such as children and adolescents (86, 260) or those 
with severe medical comorbidity. Tasks on the least invasive 
spectrum are the most suited to widespread use across diverse 
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participants, but they tend to suffer from floor effects, something 
especially true with cardiac interoception (16). One noteworthy 
exception may be the combination of interoceptive attention 
tasks with functional neuroimaging, which have demonstrated 
insula activation in health samples (14, 15) as well as psychiatric 
patient samples (157, 162, 235).
All of the aforementioned approaches have good psycho-
metric properties due to the ability to produce parametric 
perturbations in either dose, load, or inflation pressure. In other 
words, as the levels of stimulation increase, subjective reports 
of domain specific intensity reliably and reproducibly increase. 
However, despite good construct validity, there is limited data 
available regarding test–retest reliability. Additional studies are 
also needed to evaluate individual differences in cross modal 
interoception [e.g., Holzl et  al. (261); Herbert et  al. (22)]. The 
following represents a representative review illustrating some of 
the best available data on interoception reliability within specific 
interoceptive facets.
A study of heartbeat detection involving two visits across sepa-
rate days observed only a moderate correlation between accuracy 
across visits (r = 0.45, p < 0.0003, Cronbach’s alpha = 0.62) (262). 
In that study, age accounted for 30% of the variance in interocep-
tive accuracy. A study of the relationship between interoceptive 
accuracy on heartbeat counting versus heartbeat detection in 
the same subjects found a low correlation between the tasks 
(r = 0.316, p = 0.004) (33). An isoproterenol study of heartbeat 
perception, involving two bolus infusion sessions in the same day 
separated by a meal, found that accuracy scores were significantly 
correlated across the different meal points in both the anorexia 
nervosa and healthy comparison groups (21). For example, both 
groups displayed moderate positive correlations between pre 
and post meal measurements at the 2 mcg dose (HC: r = 0.58, 
p = 0.02; AN: r = 0.47, p = 0.009) and showed high correlations at 
the 4 mcg dose (HC: r = 0.72, p = 0.003; AN: r = 0.86, p < 0.001). 
A study of bladder interoception using two scales to measure 
bladder fullness versus urination urge found that ratings on each 
scale were significantly related to bladder volume, with good to 
excellent intraclass correlations across two 3-day periods (ICCs 
typically 0.7 or greater). However, in that study, the setting in 
which ratings were obtained substantially impacted the agree-
ment between subjective ratings and observed voided volume. 
Patients with overactive bladders and healthy volunteers both 
tended to rate bladder fullness and urinary urge higher when 
they were observed in a hospital setting than when measure-
ments were taken at home. A study using the Multidimensional 
Assessment of Interoceptive Awareness (MAIA) scale as a self-
report measure of interoception in chronic low back pain found 
that Cronbach’s alphas for six of the eight MAIA scales ranged 
from 0.74 to 0.90 across the total sample (263). In the next sec-
tion, we highlight important criteria to consider when selecting 
measures of interoception.
iMPORTANT SeLeCTiON CRiTeRiA FOR 
iNTeROCePTiON TASKS
It is highly advantageous to select measures that allow for 
perturbation of the interoceptive system being targeted. This 
allows for parametric modulation and simultaneous com-
parison with symptom report, physiology, and nervous system 
function. However, since such paradigms are often intricate, 
it is important to also measure symptoms in a minimalistic 
manner to allow for naturalistic assessments of symptom report, 
physiology, and nervous system function. We recommend a 
combination of the two approaches. For example, if targeting 
cardiac interoception in anorexia nervosa, it might be optimal 
to measure cardiac sensitivity using both an interoceptive atten-
tion task [as in Kerr et al. (235)] and separately, an isoproterenol 
infusions task [as in Khalsa et al. (21)]. If targeting respiratory 
interoception, it might be optimal to measure respiratory 
sensitivity using both an inspiratory breathing load task [as 
in Paulus et  al. (19)], and a carbon dioxide inhalation task 
[as in Pine et  al. (86)].
Using tasks which dynamically perturb interoceptive systems 
have four major advantages: (1) they allow for the identification 
of interoceptive phenomenon not present during baseline states 
(4). (2) They bypass the limitations of floor effects, which are 
especially well documented for the cardiovascular system. (3) 
They facilitate the manipulation of environmental context and 
expectancies in a mechanistic fashion. This approach is ideal for 
investigating the impact of perceived controllability on symp-
tom reports (144). (4) They are more naturalistic. Interoceptive 
exposure manipulations in the outpatient clinic setting are 
often somewhat constructed (e.g., breathing through straws of 
different diameters, doing pushups or jumping jacks, spinning 
in a chair, sitting in front of a heater). They are also sometimes 
variably effective at eliciting anxiety: some patients may show 
greater sensitivity to respiratory signals and others more to car-
diac signals or dizziness. Some patients may also develop rapid 
tolerance to these measures despite the continued presence of 
elevated anxiety and/or panic attacks (the presence of residual 
or surreptitious avoidance behaviors must first be thoroughly 
excluded). In such cases, interoceptive modulations might poten-
tially boost the efficacy of exposure therapy. For example, there 
is experimental evidence that pharmacological interoceptive 
exposure therapy can reduce anxiety disorder symptom severity 
either as a monotherapy (84, 140–142) or as an augmentative 
approach (143). However, with few studies to date, the impact 
of such interventions on longer term outcomes (e.g., 6 months 
or beyond) are unknown, and none of these approaches have 
translated into regular clinical practice. Developing augmented 
interoceptive exposures might therefore potentially boost the 
efficacy of interoceptive exposures by using more potent stimuli 
that modulate both physiological homeostasis and the percep-
tion of controllability.
We would also recommend collecting multiple organ system 
measures of interoceptive modulation, in order to develop an 
“interoceptive profile” of a person. This could be accomplished 
by independently modulating the cardiovascular, respiratory, 
gastrointestinal, urinary systems, and comparing the self-report 
data with simultaneous measures of behavior, physiology, and 
neural circuits, all within the same individual. Conducting such 
structured and systematic investigations could yield substantial 
insights into the pathophysiology underlying psychiatric disor-
ders marked by dirsturbed bodily processing.
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MiNDiNG PRACTiCALiTY iN 
iNTeROCePTiON ReSeARCH
Ultimately, for interoception measures to become meaningful, 
they must allow researchers to test strong hypotheses about 
clinically relevant issues. One practical example of future 
interoceptive exposure-based therapy might be to assess a 
patient’s responses to interoceptive challenges across several 
systems (e.g., cardiovascular, respiratory, and gastrointestinal) 
to obtain real time calibrated dose–response measures of physi-
ological dysfunction – not simply negative affect induced by a 
stimulus. This could provide a patient-specific “interoceptive 
profile” delineating where abnormalities occur: perhaps a noisy 
baseline (increased false positives during placebo stimula-
tion) or hypersensitivity (left-shifted dose response curve). 
Subsequent treatments could involve interventions designed to 
normalize interoceptive and affective imbalances, with efficacy 
acutely assessed via profile normalization (attenuating baseline 
variability or shifting the interoceptive dose response curve 
to the right) and chronic efficacy maintained via tolerance of 
periodically repeated challenges. To be clinically meaningful, 
such neuroscience-based tools would need to have good con-
struct validity (correspond meaningfully to relevant clinical 
symptoms), be reproducible (have good test–retest reliability), 
be easily interpretable by individual clinicians and patients 
during their treatment decision-making process, and readily 
incorporable into psychiatry residency and psychology intern-
ship education. Finally, although we have focused on several 
psychiatric disorders in this review to illustrate common and 
divergent themes, other disorders are worthy of future consid-
ideration including posttraumatic stress disorder and autism 
spectrum disorders.
CONCLUSiON
In summary, the study of interoception in psychopathology 
represents a viable avenue for clinical and translational research 
in psychiatry with (1) a well-established conceptual framework 
relevant to a variety of psychiatric disorders, (2) a neural basis, 
(3) measurable biomarkers, (4) interdisciplinary appeal that 
may help bridge the gap between disciplines, and (5) numerous 
transdiagnostic points of intervention for understanding and 
improving mental health outcomes.
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